Implementing a target systolic blood pressure (SBP) of <120 mm Hg is recommended for adults with CKD, when tolerated, to slow disease progression and reduce cardiovascular risk.
First-line pharmacological interventions include ACE inhibitors or angiotensin receptor blockers (ARBs), particularly in patients with elevated albuminuria or reduced eGFR.
Personalized dialysis plans are essential, considering factors like residual kidney function, comorbidities, and patient preferences.
Regular monitoring and adjustment of dialysis prescriptions are crucial to optimize patient outcomes and minimize complications.
Thorough evaluation of transplant candidates, including immunological assessments and psychosocial evaluations, is vital.
Post-transplant care focuses on immunosuppressive therapy management, infection prevention, and monitoring for graft function.
Aggressive glycemic control and blood pressure management are paramount to prevent or slow the progression of diabetic nephropathy.
Regular screening for albuminuria and eGFR is recommended for early detection and intervention.
Early identification and management of AKI are critical to prevent progression to chronic kidney disease.
Treatment strategies include optimizing fluid balance, avoiding nephrotoxic agents, and considering renal replacement therapy when indicated.